Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

LUN00-12

A Randomized, Phase III Trial Comparing CPT-11/ Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated, Extensive Small-Cell Lung Cancer

Abstracts/Posters/Presentations:

  • A Sandler, C Langer, P Bunn, L Einhorn A Randomized Phase III Trial Comparing CPT-11 (Irinotecan HCl; Camptosar Injection)/Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated, Extensive, Small-Cell Lung Cancer: A Hoosier Oncology Group Study LUN00-12. Poster presentation at the ASCO annual meeting May 31-June 3, 2003, Chicago, IL
  • A Sandler, C Langer, P Bunn, L Einhorn. Interim Safety Analysis of Irinotecan and Cisplatin Combination Chemotherapy for Previously Untreated Extensive Small Cell Lung Cancer LUN00-12. Accepted to the ASCO annual meeting May 13-17, 2005 in Orlando, Florida

Manuscripts/Articles:

  • Nasser Hanna, Paul Bunn, Jr., Corey Langer, Lawrence Einhorn, Troy Guthrie, Jr., Thaddeus Beck, Rafat Ansari, Peter Ellis, Michael Byrne, Mark Morrison, Subramanian Hariharan, Benjamin Wang, Alan Sandler. Randomized Phase II Trial Comparing Irinotecan/Cisplatin with Etoposide/Cisplatin in Patients with Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer LUN00-12. J Clin Oncol 2006; 24:2038-2046